Skip to main content
. 2012 Sep 12;2012(9):CD004418. doi: 10.1002/14651858.CD004418.pub4

Lode 1995.

Methods Randomized 
 Multicenter
Participants Adults (mean age: 54) 
 Hospitalized and outpatients 
 CAP
Interventions Atypical: PO sparfloxacin 400 mg loading dose, followed by PO sparfloxacin 200 mg X 1/d 
 PO erythromycin 1 G X 2/d 
 Non‐atypical: PO amoxicillin‐clavulanic acid 500/125 mg X 3/d
Outcomes Failure = clinical, radiological, change of antibiotics 
 Modification = failure
Notes 3 arms in 2:1:1 randomizations (sparfloxacin: amoxicillin‐clavulanic acid: erythromycin); the two atypical arms were calculated as one, in comparison to the non‐atypical arm 
 Note: also outpatients ‐ no further data, short of stating the majority of patients were hospitalized
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described
Allocation concealment (selection bias) Unclear risk Not described
Incomplete outcome data (attrition bias) 
 Mortality Low risk All patients evaluated
Incomplete outcome data (attrition bias) 
 Failure Low risk All patients evaluated
Selective reporting (reporting bias) Low risk Not identified
Other bias Unclear risk Sponsored
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Double‐blind
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Double‐blind